According to Cerus's latest financial reports the company's total assets are $0.19 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.19 B | -9.33% |
2022-12-31 | $0.21 B | -8.17% |
2021-12-31 | $0.23 B | 7.26% |
2020-12-31 | $0.22 B | 33.76% |
2019-12-31 | $0.16 B | 1.27% |
2018-12-31 | $0.16 B | 66.38% |
2017-12-31 | $98.24 M | -5.06% |
2016-12-31 | $0.10 B | -25.77% |
2015-12-31 | $0.13 B | 70.47% |
2014-12-31 | $81.77 M | -1.92% |
2013-12-31 | $83.38 M | 70.45% |
2012-12-31 | $48.91 M | 7.83% |
2011-12-31 | $45.36 M | -5.81% |
2010-12-31 | $48.16 M | 39.65% |
2009-12-31 | $34.49 M | -27.14% |
2008-12-31 | $47.33 M | -39.47% |
2007-12-31 | $78.2 M | -32.47% |
2006-12-31 | $0.11 B | 97.44% |
2005-12-31 | $58.66 M | -42.53% |
2004-12-31 | $0.10 B | -13.83% |
2003-12-31 | $0.11 B | 62.4% |
2002-12-31 | $72.94 M | -43.13% |
2001-12-31 | $0.12 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Boston Scientific BSX | $35.13 B | 17,668.07% | ๐บ๐ธ USA |
Utah Medical Products UTMD | $0.13 B | -33.63% | ๐บ๐ธ USA |
Haemonetics HAE | $2.20 B | 1,012.74% | ๐บ๐ธ USA |
Eterna Therapeutics ERNA | $49.13 M | -75.15% | ๐บ๐ธ USA |